RETIGEN

Welcome to the Brand page for “RETIGEN”, which is offered here for Pharmaceutical drugs and drug treatments, and informational materials to assist in the treatment and understanding of ocular disease, including macular degeneration and diabetic retinopathy; and its side effects;the development, manufacture, administration, sale and distribution of pharmaceutical drugs and drug treatments, and informational materials relating to the treatment and understanding of ocular disease, including macular degeneration and diabetic retinopathy; and its side effects;.

Its status is currently believed to be active. Its class is unavailable. “RETIGEN” is believed to be currently owned by “Resverlogix Corp.”